DelSiTech Ltd

DelSiTech Ltd is Recruiting an Analytical Scientist. See the details and apply below. https://lnkd.in/d2UkYADS

🚀 Exciting News from DelSiTech Ltd! We’re thrilled to announce that Carl-Åke Carlsson has joined DelsiTech as our new CEO! With over 30 years of pharma industry experience, Carl-Åke brings a wealth of knowledge to guide DelsiTech into its next phase of growth. Carl-Åke's leadership will be instrumental as we continue to innovate with our 𝐃𝐞𝐥𝐒𝐢𝐓𝐞𝐜𝐡™ 𝐒𝐢𝐥𝐢𝐜𝐚 𝐌𝐚𝐭𝐫𝐢𝐱 technology, strengthening our focus on long-acting injectable and ophthalmic drug delivery solutions that address critical patient needs. Join us in welcoming Carl-Åke Carlsson to the team as we work toward a future where transformative treatments improve lives worldwide. https://lnkd.in/dAP-FtMw Learn more about our vision and what’s ahead for DelsiTech: www.delsitech.com

DelSiTech Ltd is recruiting and excited to announce an open position - Finance Manager. See the details and apply below. https://lnkd.in/dTfsUEcs

Don't forget DelSiTech Ltd is hosting a webinar focusing on long-acting injectable technologies starting on the 12th of September. If you are interested in hearing from leaders in the long-acting injectable field, there is still time to register from the link below. We look forwards to seeing you all there! https://lnkd.in/e8dqSNu7

We are honored to be recognized by our hometown once again with the "Growth in Sight" award as a part of the Turku Europe Forum Event 2024. The award acknowledges DelSiTech Ltds significant potential for future growth, but also the notable positive impact we are able to have on the growth and development opportunities of our local community. Read more from the link below: https://bit.ly/3Z8ppN9

DelSiTech Ltd is excited to be hosting a webinar focusing on long-acting injectables starting on the 12th of September, chaired by Dr. Frederic Dargelas, PhD, MBA. It is a real privilege to have Prof. René Holm of the University of Southern Denmark, Dr. Peter Markland of Tolmar Pharmaceuticals, and Dr. Jokinen Mika of DelSiTech provide their unique perspectives on the long-acting injectable technology space as it stands today. We believe that long-acting injectables are already and will increasingly be transformative forms of care for patients around the globe. In support of bringing these technologies and treatments to patients, we are pleased to note that the webinar can be attended free of charge. To attend, go ahead and fill out the registration form through the link below: https://lnkd.in/e8dqSNu7 Many thanks to Arena International Webinars for helping us organize this opportunity.

DelSiTech Ltd is excited to announce the appointment of Mr. Carl-Åke Carlsson to its Board of Directors! Read more from the full press release below.

💉 DelSiTech Ltd is thrilled to announce an exclusive licensing agreement with a leading global pharmaceutical company!   This exclusive agreement grants them rights to our groundbreaking #SilicaMatrix controlled release technology for the development and commercialization of an undisclosed long-acting injectable drug product. Under the terms of the agreement, #DelSiTech will receive an upfront payment of $9M and potential milestone payments exceeding $200M, plus royalties on net sales.   This is the second global license agreement to be announced by DelSiTech in 2024 and we look forward to sharing more updates in the future. Read the full press release linked in the comments below!   #DelSiTech #DrugDelivery #LicensingAgreement